Vendor cuts layer of middle managementGE Medical Systems has overhauled its sales and marketing organization,cutting out an entire layer of management and introducing a strategicmarket segment concept to augment the company's traditional focuson
GE Medical Systems has overhauled its sales and marketing organization,cutting out an entire layer of management and introducing a strategicmarket segment concept to augment the company's traditional focuson modalities. The reorganization was prompted by the need toget closer to customers, according to Paul Mirabella, vice presidentand general manager of sales.
"We need an organization to be fast-moving and very, veryresponsive to what customers need, without filters or unnecessarylayers," Mirabella said.
The Milwaukee-based company previously used a geographicallyoriented organization that included zone managers who interacteddirectly with customers and reported to regional managers, whoin turn reported to general managers. The new plan, in effectsince early June, establishes a series of managers to whom thesales reps report. The reps usurped the regional managers' titlesheld by their bosses.
"It is a significant name change in that they now behaveas a business unit, the same as the previous regional managers,but they work directly with the customer," Mirabella said.
These 22 newly assigned regional managers report directly toMirabella, as do 12 other managers. Several of the others arecharged with market segments that are application-specific, suchas cardiology, women's health and oncology.
These segment managers must look for opportunities that involvethe integration of several modalities. For example, cardiologyholds opportunities for sales of nuclear medicine, cardiac catheterizationand ultrasound. The manager of that market segment works withthe managers of modalities such as x-ray, ultrasound and nuclearmedicine.
The cardiology segment will allow for the future addition ofMR, which GE is developing as a one-stop shop for cardiac evaluation.
Not all opportunities will arise in applications areas, however.The new GE structure acknowledges that reality with the establishmentof segments such as installed-base marketing, new growth initiativesand integrated marketing programs.
"Because our installed base is so huge, we also treatthe installed base as a market segment," Mirabella said.
Three general managers are included among the dozen executiveswho report to Mirabella. They wear three different hats, fittingthree areas of responsibility:
The changeover to this new organizational structure has beengreeted by excitement at GE, but the company also has some concerns.
"You enter into these things with a lot of confidence,because you are (building) them and you know what you want toaccomplish," Mirabella said. "But there is also a littletrepidation, because it could be overwhelming if the transitionis not handled right."
GE staff apparently have risen to the challenge with a doublingof business from May to June, Mirabella said. Although that riseis not entirely attributable to the organizational change, Mirabellais happy with the apparent effectiveness of the reorganizationin meeting initial goals.
"We are getting a lot of high-level resources, all theway up to John Trani, involved in every aspect of the business,"Mirabella said. "Response is relatively instantaneous."
Study: AI Boosts Ultrasound AUC for Predicting Thyroid Malignancy Risk by 34 Percent Over TI-RADS
February 17th 2025In a study involving assessment of over 1,000 thyroid nodules, researchers found the machine learning model led to substantial increases in sensitivity and specificity for estimating the risk of thyroid malignancy over traditional TI-RADS and guidelines from the American Thyroid Association.
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
February 14th 2025For the assessment of contrast-enhanced abdominopelvic CT exams, an artificial intelligence model demonstrated equivalent or better sensitivity than radiologist readers, and greater than 90 percent specificity for the diagnosis of colorectal cancer.
Emerging PET/CT Agent Shows Promise in Detecting PCa Recurrence in Patients with Low PSA Levels
February 13th 202518F-DCFPyL facilitated detection of recurrent prostate cancer in 51 percent of patients with PSA levels ranging between 0.2 to 0.5 ng/ml, according to new research presented at the American Society of Clinical Oncology Genitourinary Cancers (ASCO-GU) Symposium.